Avance Clinical CEO On Biotech Funding Green Shoots, Oncology Study Design Landscape
Avance To Support South Korean Biotechs
Executive Summary
Avance Clinical’s CEO talks to Scrip about green shoots in US biotech funding, potential partnering in the AI space, the Australia rapid-start draw for early phase trials and the transition in the study design landscape in oncology for first-in-human trials.